의약품 관련 법령
Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-31 | 조회수 | 648 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM612037.pdf | ||
첨부파일 |
Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
- 이전글 Assessing User Fees Under the Biosimilar User Fee Amendments of 2017 Guidance for Industry
- 다음글 ANDA Submissions — Amendments to Abbreviated New Drug Applications Under GDUFA